Literature DB >> 24882555

A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer.

Abdulrahman K Sinno1, Amanda Nickles Fader1, Kara Long Roche1, Robert L Giuntoli1, Edward J Tanner2.   

Abstract

OBJECTIVE: The study objective was to compare the ability to detect sentinel lymph nodes (SLNs) in women with endometrial cancer (EC) or complex atypical hyperplasia (CAH) using fluorometric imaging with indocyanine green (ICG) versus colorimetric imaging with isosulfan blue (ISB).
METHODS: Women underwent SLN mapping, with either ISB or ICG, during robotic-assisted total laparoscopic hysterectomy (RA-TLH) from September 2012 to March 2014. SLNs were submitted for permanent pathologic analysis. Completion lymphadenectomy and ultrastaging were performed according to institutional protocols.
RESULTS: RA-TLH and SLN mapping was performed in 71 women; 64 had EC (64) and 7 had CAH. Age, body mass index (BMI), stage and tumor characteristics were similar in the ICG versus the ISB cohorts. Overall, SLNs were identified bilaterally (62.0%), unilaterally (21.1%), or neither (16.9%), and in 103 of 142 hemi-pelvises (72.5%). The mean number of SLNs retrieved per hemipelvis was 2.23(SD 1.7). SLNs were identified in the hypogastric (76.8%), external iliac (14.2%), common iliac (4.5%) and paraaortic (4.5%) regions. ICG mapped bilaterally in 78.9% of women compared with 42.4% of those injected with ISB (p=0.02). Five women (7%) had positive lymph nodes, all identified by the SLN protocol (false negative rate: 0%). On multivariate analysis, BMI was negatively correlated with bilateral mapping success (p=0.02). When stratified by dye type, the association with BMI was only significant for ISB (p=0.03).
CONCLUSIONS: Fluorescence imaging with ICG may be superior to colorimetric imaging with ISB in women undergoing SLN mapping for endometrial cancer. SLN mapping success is negatively associated with increasing patient BMI only when ISB is used.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endometrial cancer; Fluorescence imaging; Indocyanine green; Obesity; Robotic hysterectomy; Sentinel lymph node

Mesh:

Substances:

Year:  2014        PMID: 24882555     DOI: 10.1016/j.ygyno.2014.05.022

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  32 in total

Review 1.  New Developments in Minimally Invasive Gynecologic Oncology Surgery.

Authors:  Katherine Ikard Stewart; Amanda N Fader
Journal:  Clin Obstet Gynecol       Date:  2017-06       Impact factor: 2.190

2.  Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery.

Authors:  Ane Gerda Zahl Eriksson; Margaret Montovano; Anna Beavis; Robert A Soslow; Qin Zhou; Nadeem R Abu-Rustum; Ginger J Gardner; Oliver Zivanovic; Richard R Barakat; Carol L Brown; Douglas A Levine; Yukio Sonoda; Mario M Leitao; Elizabeth L Jewell
Journal:  Ann Surg Oncol       Date:  2016-02-23       Impact factor: 5.344

Review 3.  Advances in fluorescent-image guided surgery.

Authors:  Mark J Landau; Daniel J Gould; Ketan M Patel
Journal:  Ann Transl Med       Date:  2016-10

Review 4.  Surgical staging in endometrial cancer.

Authors:  Maria Luisa Gasparri; Donatella Caserta; Pierluigi Benedetti Panici; Andrea Papadia; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2018-11-20       Impact factor: 4.553

Review 5.  Beyond the margins: real-time detection of cancer using targeted fluorophores.

Authors:  Ray R Zhang; Alexandra B Schroeder; Joseph J Grudzinski; Eben L Rosenthal; Jason M Warram; Anatoly N Pinchuk; Kevin W Eliceiri; John S Kuo; Jamey P Weichert
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

6.  Utilization of sentinel lymph node biopsy for uterine cancer.

Authors:  Jason D Wright; Stephanie Cham; Ling Chen; William M Burke; June Y Hou; Ana I Tergas; Vrunda Desai; Jim C Hu; Cande V Ananth; Alfred I Neugut; Dawn L Hershman
Journal:  Am J Obstet Gynecol       Date:  2017-02-16       Impact factor: 8.661

Review 7.  Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue.

Authors:  Andrea Papadia; Maria Luisa Gasparri; Alessandro Buda; Michael D Mueller
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-21       Impact factor: 4.553

Review 8.  Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.

Authors:  Robert W Holloway; Nadeem R Abu-Rustum; Floor J Backes; John F Boggess; Walter H Gotlieb; W Jeffrey Lowery; Emma C Rossi; Edward J Tanner; Rebecca J Wolsky
Journal:  Gynecol Oncol       Date:  2017-05-28       Impact factor: 5.482

9.  Sentinel lymph node detection rates using indocyanine green in women with early-stage cervical cancer.

Authors:  Anna L Beavis; Sergio Salazar-Marioni; Abdulrahman K Sinno; Rebecca L Stone; Amanda N Fader; Antonio Santillan-Gomez; Edward J Tanner
Journal:  Gynecol Oncol       Date:  2016-08-12       Impact factor: 5.482

10.  Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.

Authors:  Ane Gerda Zahl Eriksson; Jen Ducie; Narisha Ali; Michaela E McGree; Amy L Weaver; Giorgio Bogani; William A Cliby; Sean C Dowdy; Jamie N Bakkum-Gamez; Nadeem R Abu-Rustum; Andrea Mariani; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2015-12-31       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.